These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 35948253)
21. Anti-NMDA receptor encephalitis presenting as postpartum psychosis-a clinical description and review. Reddy MSS; Thippeswamy H; Ganjekar S; Nagappa M; Mahadevan A; Arvinda HR; Chandra PS; Taly AB Arch Womens Ment Health; 2018 Aug; 21(4):465-469. PubMed ID: 29417305 [TBL] [Abstract][Full Text] [Related]
22. Anti-NMDA receptor encephalitis: psychiatric presentation and diagnostic challenges from psychosomatic medicine perspective. Gulyayeva NA; Massie MJ; Duhamel KN Palliat Support Care; 2014 Apr; 12(2):159-63. PubMed ID: 24635944 [TBL] [Abstract][Full Text] [Related]
23. Olanzapine and Lorazepam Used in the Symptomatic Management of Excited Catatonia Secondary to Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Neerukonda N; Bliss M; Jafroodifar A; Leontieva L Cureus; 2020 Jun; 12(6):e8689. PubMed ID: 32577332 [TBL] [Abstract][Full Text] [Related]
24. Significant efficacy of electroconvulsive therapy on the behavioural symptoms of anti-N-methyl-d-aspartate receptor encephalitis. Kim S; Horiuchi K; Ueda T; Boku S BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38307623 [TBL] [Abstract][Full Text] [Related]
25. Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis. Warren N; Siskind D; O'Gorman C Acta Psychiatr Scand; 2018 Nov; 138(5):401-408. PubMed ID: 29992532 [TBL] [Abstract][Full Text] [Related]
26. Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: Case report. Kramina S; Kevere L; Bezborodovs N; Purvina S; Rozentals G; Strautmanis J; Viksna Z Psych J; 2015 Dec; 4(4):226-30. PubMed ID: 26663628 [TBL] [Abstract][Full Text] [Related]
27. A Case of Anti-NMDA Receptor Encephalitis Treated with ECT. Jones KC; Schwartz AC; Hermida AP; Kahn DA J Psychiatr Pract; 2015 Sep; 21(5):374-80. PubMed ID: 26348805 [TBL] [Abstract][Full Text] [Related]
28. Complete cognitive recovery in a severe case of anti-N-methyl-d-aspartate receptor encephalitis treated with electroconvulsive therapy. Leding C; Marstrand L; Jorgensen A BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32034002 [TBL] [Abstract][Full Text] [Related]
30. Anti-NMDA receptor encephalitis with associated catatonia during pregnancy. McCarthy A; Dineen J; McKenna P; Keogan M; Sheehan J; Lynch T; O'Rourke K J Neurol; 2012 Dec; 259(12):2632-5. PubMed ID: 22752087 [TBL] [Abstract][Full Text] [Related]
31. Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions. Kuppuswamy PS; Takala CR; Sola CL Gen Hosp Psychiatry; 2014; 36(4):388-91. PubMed ID: 24731834 [TBL] [Abstract][Full Text] [Related]
32. A Multimedia Description of Catatonia Secondary to Anti-NMDA-Receptor Encephalitis. Dalapati T; Robbins-Welty G; Wolthusen RPF; Staplefoote-Boynton L; Diocares A; Skeen MB; Gagliardi JP Prim Care Companion CNS Disord; 2023 Sep; 25(5):. PubMed ID: 37788802 [No Abstract] [Full Text] [Related]
33. A Case of Ovarian Teratoma-Induced N-Methyl-D-Aspartate Receptor Antibody Encephalitis Presenting With Psychosis and Catatonia, Progressing to the Minimally Conscious State and Successfully Treated With Adjunctive Zolpidem. Spiegel DR; Ahuja K; Reid FE; Hegde S; Carbaugh E; Tran V; Forte S; Strauss E; Lagbo J; Lau J Prim Care Companion CNS Disord; 2023 Aug; 25(4):. PubMed ID: 37549432 [No Abstract] [Full Text] [Related]
34. Anti-NMDA receptor encephalitis in a 14-year-old female presenting as malignant catatonia: medical and psychiatric approach to treatment. Wilson JE; Shuster J; Fuchs C Psychosomatics; 2013; 54(6):585-9. PubMed ID: 23849593 [No Abstract] [Full Text] [Related]
35. Refractory Catatonia Due to N-methyl-D-Aspartate Receptor Encephalitis Responsive to Electroconvulsive Therapy: The Clinical Use of the Clock Drawing Test. Medina M; Cooper JJ J ECT; 2017 Dec; 33(4):223-224. PubMed ID: 28658010 [No Abstract] [Full Text] [Related]
36. Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports. Maggio MC; Mastrangelo G; Skabar A; Ventura A; Carrozzi M; Santangelo G; Vanadia F; Corsello G; Cimaz R J Med Case Rep; 2017 Aug; 11(1):225. PubMed ID: 28810906 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis in patients with a long-term history of mental disorders. Wang HY; Yang XY; Han J; Liu H; Yan ZR; Liang Z Eur J Med Res; 2022 Mar; 27(1):38. PubMed ID: 35272706 [TBL] [Abstract][Full Text] [Related]
38. Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature. Wright MA; Guasp M; Lachner C; Day GS; Gombolay G; Titulaer MJ; Clardy SL J Neuroimmunol; 2024 Jul; 392():578369. PubMed ID: 38823118 [TBL] [Abstract][Full Text] [Related]
39. Non-N-methyl-D-aspartate Autoimmune Encephalopathy and Catatonia Treated With Electroconvulsive Therapy: A Pediatric Case Series and Treatment Guidelines. Mischel NA; Mooneyham GC; Lau C; Van Mater H; Weiner RD Psychosomatics; 2020; 61(6):834-839. PubMed ID: 31980211 [No Abstract] [Full Text] [Related]
40. Anti-NMDAR encephalitis: a new, severe and challenging enduring entity. van de Riet EH; Esseveld MM; Cuypers L; Schieveld JN Eur Child Adolesc Psychiatry; 2013 May; 22(5):319-23. PubMed ID: 23250735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]